| Code | 6955D | ||||||||||
| MA number | 26/0079/21-S | ||||||||||
| Product Form: | plc ifc 1x30 ml/100 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olikla s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.04.2021 |
| Validity: | 16.04.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Anidulafungin Olikla 100 mg prášok na koncentrát na infúzny roztok_04.2023.pdf
|
| SPC: |
SPC_Anidulafungin Olikla 100 mg prášok na koncentrát na infúzny roztok_04.2023.pdf
|
| Safety feature | Yes |
| Data update: | 07.05.2021 |
